Average Co-Inventor Count = 7.31
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ariad Pharmaceuticals, Inc. (22 from 69 patents)
2. Amgen Inc. (9 from 1,974 patents)
3. Genentech, Inc. (1 from 3,222 patents)
4. Takeda Pharmaceutical Company Limited (1 from 1,179 patents)
5. Regor Pharmaceuticals, Inc. (0 patent)
6. Dalgarno, David C. (0 patent)
7. Zhu, Xiaotian (0 patent)
8. Wang, Yihan (0 patent)
9. Huang, Wei-sheng (0 patent)
10. Shakespeare, William C. (0 patent)
33 patents:
1. 12285429 - CDK inhibitors
2. 11958850 - Heteroaryl compounds for kinase inhibition
3. 11753404 - Aminothiazole compounds as c-Kit inhibitors
4. 11180482 - Anilinopyrimidines as haematopoietic progenitor kinase 1 (HPK1) inhibitors
5. 11117883 - Benzimidazole compounds as c-Kit inhibitors
6. 11001580 - Aminothiazole compounds as c-Kit inhibitors
7. 10227342 - Heteroaryl compounds for kinase inhibition
8. 9834521 - Choline kinase inhibitors
9. 9834518 - Compounds for inhibiting cell proliferation in EGFR-driven cancers
10. 9834571 - Compounds for inhibiting cell proliferation in EGFR-driven cancers
11. 9796712 - Heteroaryl compounds for kinase inhibition
12. 9278971 - Substituted acetylenic pyrazolo[1,5-a]pyrimidines as kinase inhibitors
13. 9273077 - Phosphorus derivatives as kinase inhibitors
14. 9090561 - Acetylenic heteroaryl compounds
15. 9029533 - Substituted acetylenic imidazo[1,2-A]pyridazines as kinase inhibitors